Cargando…

CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer

PURPOSE: CATCH (Comprehensive Assessment of clinical feaTures and biomarkers to identify patients with advanced or metastatic breast Cancer for marker driven trials in Humans) is a prospective precision oncology program that uses genomics and transcriptomics to guide therapeutic decisions in the cli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hlevnjak, Mario, Schulze, Markus, Elgaafary, Shaymaa, Fremd, Carlo, Michel, Laura, Beck, Katja, Pfütze, Katrin, Richter, Daniela, Wolf, Stephan, Horak, Peter, Kreutzfeldt, Simon, Pixberg, Constantin, Hutter, Barbara, Ishaque, Naveed, Hirsch, Steffen, Gieldon, Laura, Stenzinger, Albrecht, Springfeld, Christoph, Smetanay, Katharina, Seitz, Julia, Mavratzas, Athanasios, Brors, Benedikt, Kirsten, Romy, Schuetz, Florian, Fröhling, Stefan, Sinn, Hans-Peter, Jäger, Dirk, Thewes, Verena, Zapatka, Marc, Lichter, Peter, Schneeweiss, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2021
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140780/ https://www.ncbi.nlm.nih.gov/pubmed/34036222 http://dx.doi.org/10.1200/PO.20.00248

Ejemplares similares

Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions
por: Wong, John K. L., et al.
Publicado: (2022)

COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy
por: Pixberg, C., et al.
Publicado: (2022)

The landscape of chromothripsis across adult cancer types
por: Voronina, Natalia, et al.
Publicado: (2020)

Successful BRAF/MEK inhibition in a patient with BRAF(V600E)-mutated extrapancreatic acinar cell carcinoma
por: Busch, Elena, et al.
Publicado: (2020)

A novel cloning strategy for one-step assembly of multiplex CRISPR vectors
por: Zuckermann, Marc, et al.
Publicado: (2018)

Community-driven development of a modified progression-free survival ratio for precision oncology
por: Mock, Andreas, et al.
Publicado: (2019)

Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance
por: Horak, Peter, et al.
Publicado: (2019)

Correction to: Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations
por: Simon, Malte, et al.
Publicado: (2022)

Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations
por: Simon, Malte, et al.
Publicado: (2021)

Age-Dependent Hematologic Toxicity Profiles and Prognostic Serologic Markers in Postoperative Radiochemotherapy Treatment for Uterine Cervical Cancer
por: Meixner, Eva, et al.
Publicado: (2022)

Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification
por: Gröschel, Stefan, et al.
Publicado: (2016)

Changes in chemotherapy usage and outcome of early breast cancer patients in the last decade
por: Hennigs, A., et al.
Publicado: (2016)

Frequent Molecular Subtype Switching and Gene Expression Alterations in Lung and Pleural Metastasis From Luminal A–Type Breast Cancer
por: Klebe, Max, et al.
Publicado: (2020)

confFuse: High-Confidence Fusion Gene Detection across Tumor Entities
por: Huang, Zhiqin, et al.
Publicado: (2017)

Genome-wide identification of translationally inhibited and degraded miR-155 targets using RNA-interacting protein-IP
por: Meier, Jan, et al.
Publicado: (2013)

Capture and Amplification by Tailing and Switching (CATS): An ultrasensitive ligation-independent method for generation of DNA libraries for deep sequencing from picogram amounts of DNA and RNA
por: Turchinovich, Andrey, et al.
Publicado: (2014)

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfalls
por: Horak, Peter, et al.
Publicado: (2016)

Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer
por: Hoeltgen, Line, et al.
Publicado: (2023)

Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
por: Gröschel, Stefan, et al.
Publicado: (2019)

Coverage Bias and Sensitivity of Variant Calling for Four Whole-genome Sequencing Technologies
por: Rieber, Nora, et al.
Publicado: (2013)

CITED4 gene silencing in colorectal cancer cells modulates adherens/tight junction gene expression and reduces cell proliferation
por: Rogers, Michael A., et al.
Publicado: (2015)

Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards
por: Rieke, Damian T., et al.
Publicado: (2022)

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity
por: Möhrmann, Lino, et al.
Publicado: (2022)

Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia
por: Horak, Peter, et al.
Publicado: (2020)

Publisher Correction: Comprehensive genomic characterization of gene therapy-induced T-cell acute lymphoblastic leukemia
por: Horak, Peter, et al.
Publicado: (2021)

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences
por: Kriegsmann, Mark, et al.
Publicado: (2014)

Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer
por: Walter, Vincent, et al.
Publicado: (2020)

B cell-regulated immune responses in tumor models and cancer patients
por: Fremd, Carlo, et al.
Publicado: (2013)

Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks
por: Mallm, Jan‐Philipp, et al.
Publicado: (2019)

Diagnosis and Therapy of Triple-Negative Breast Cancer (TNBC) – Recommendations for Daily Routine Practice
por: Schneeweiss, Andreas, et al.
Publicado: (2019)

Accurate and efficient detection of gene fusions from RNA sequencing data
por: Uhrig, Sebastian, et al.
Publicado: (2021)

scSNPdemux: a sensitive demultiplexing pipeline using single nucleotide polymorphisms for improved pooled single-cell RNA sequencing analysis
por: Wong, John K. L., et al.
Publicado: (2023)

Double-hit lymphoma of the male breast: a case report
por: Elgaafary, Shaymaa, et al.
Publicado: (2020)

Molecular Subtype Conversion between Primary and Metastatic Breast Cancer Corresponding to the Dynamics of Apoptotic and Intact Circulating Tumor Cells
por: Stefanovic, Stefan, et al.
Publicado: (2019)

Ruxolitinib is effective in the treatment of a patient with refractory T‐ALL
por: Jaramillo, Sonia, et al.
Publicado: (2020)

Prostatic metastasis from intrahepatic cholangiocarcinoma
por: Tosev, Georgi, et al.
Publicado: (2018)

TelomereHunter – in silico estimation of telomere content and composition from cancer genomes
por: Feuerbach, Lars, et al.
Publicado: (2019)

Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial
por: Walle, Thomas, et al.
Publicado: (2020)

Integrative genomic and transcriptomic analysis of leiomyosarcoma
por: Chudasama, Priya, et al.
Publicado: (2018)

Co-expression of MET and CD47 is a novel prognosticator for survival of luminal-type breast cancer patients
por: Baccelli, Irène, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_5vv0tisbvau63lkok75jrbrig5